Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 15, 2019
Pharmacy Choice - News - Front Page Healthcare News - February 15, 2019

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

2/15/19 - 5 rural Maine hospitals, including one in bankruptcy, will get expert help to run sustainably [Bangor Daily News, Maine]
Penobscot Valley Hospital in Lincoln, Northern Light C.A. Dean Hospital in Greenville, Northern Light Sebasticook Valley Hospital in Pittsfield, Mayo Regional Hospital in Dover-Foxcroft and Calais Regional Hospital are among 25 hospitals in the nation that have won the award from the federal Office of Rural Health Policy. The award entitles them to
2/15/19 - Adial Pharmaceuticals Submits Continuation Patent Application for Use of AD04 in Opioid Dependence and Abuse
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced that it has submitted a continuation patent application with U.S. Patent and Trademark Office to broaden the claims relating to the use of AD04 for opioid dependence and abuse, commonly referred to as Opio
2/15/19 - Advanced Infusion Systems Share - Industry Size, Growth Report & Forecast - 2026: AngioDynamics, Inc., Animas Corporation, B. Braun Melsungen AG, Terumo Corpora: Overall increase in global population suffering from chronic disease, cancer, diabetes i
Valley Cottage, NY 02/15/2019 Infusion systems are medical instruments and associated disposables, used to deliver fluids or drugs in solution to patient's circulatory system in a controlled, precise and automated manner. There are different routes to introduce a drug into the patient's system, of which, highly used mode is through intravenou
2/15/19 - Agency Information Collection Activities; Proposed Collection; Comment Request; Reporting Associated With New Animal Drug Applications and Veterinary Master Files
Agency: " Food and Drug Administration, HHS." Under the Paperwork Reduction Act of 1995, Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the no
2/15/19 - ALKERMES PLC. - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations
The following should be read in conjunction with our consolidated financial statements and related notes beginning on page F 1 of this Annual Report. We earn revenue on net sales of VIVITROL, ARISTADA and ARISTADA INITIO, which are proprietary products that we manufacture, market and sell in the U.S., and manufacturing and/or royalty revenues on
2/15/19 - App Bridges Technology Gap and Disrupts Barriers to Patient Engagement
Imagine having years of your medical history available at your fingertips securely. The Health and Human Services has called for new standards issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology in securely sharing patient data across systems. When veteran healthcar
2/15/19 - Astellas and Affinivaxs novel pneumococcal vaccine enters human testing [T-break Tech (Middle East)]
About two years ago, Astellas licensed a novel pneumococcal vaccine technology from Affinivax with eyes on Pfizers Prevnar 13. The first patient has been dosed with the investigational vaccine, dubbed ASP3772, in a phase 1/ 2 study that aims to evaluate the vaccines safety, tolerability and immunogenicity, Affinivax said on Wednesday. We believe th
2/15/19 - Audit: MCO contracts did not protect state State audit says behavioral health MCO contracts did not protect state interests
A state audit released Thursday found that the contracts of North Carolina's seven behavioral health managed care organizations contracts were not precise enough to fully protect state and federal interests. Auditors determined N.C. Department of Health and Human Services' contracts with the organizations "did not always contain clear contractual..
2/15/19 - Avapritinib receives Phase III clinical trial approval for GIST in China
CStone Pharmaceuticals today announced that the National Medical Products Administration recently approved a Phase III clinical trial in China for its partnered drug candidate avapritinib as a third-line treatment against KIT-driven gastrointestinal stromal tumors. According to data from the NAVIGATOR Phase I clinical trial reported as of October
2/15/19 - Bavencio combo gets FDA priority review for kidney cancer [Sudan Tribune]
The US Food and Drug Administration has accepted for priority review a supplemental Biologics License Application for Mercks Bavencio in combination with Inlyta for patients with advanced renal cell carcinoma. "Our alliance is focused on the development of potential new treatment options for patients with cancers that have high unmet medical needs
2/15/19 - Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad s Droplet Digital PCR technology, and the QXDx BCR-ABL% IS Kit are the industry s first digital PCR products to receive U.S. Food and Drug Administration clearance. Used t
2/15/19 - Bioblast Pharma Announces Collaboration with Team Sanfilippo to Evaluate Trehalose for the Treatment of Sanfilippo Syndrome
Bioblast Pharma Ltd., a clinical-stage, orphan disease-focused biotechnology company, and Team Sanfilippo, a nonprofit medical research foundation founded by parents of children with Sanfilippo Syndrome today announced a clinical collaboration to evaluate the safety and efficacy of Bioblast s proprietary Trehalose solution for the treatment of
2/15/19 - Bluetooth Will Help IoT Enabled Medical Devices Grow At 29.9% A Year
Global IoT Enabled Healthcare Equipment Market Forecast, Market Size, 2018-2023,$ Billion. LONDON, GREATER LONDON, UK, February 15, 2019/ EINPresswire.com/ Wearable medical devices and diagnostic companies are increasingly integrating Bluetooth wireless technology with medical devices, a new report from The Business Research Company, IoT Enabled.
2/15/19 - Boustead Securities Client Soliton, Inc. Announces Closing of its IPO at $10.4 Million; Shares Set to Trade Tuesday on Nasdaq [Egypt Independent]
-via NEWMEDIAWIRE Boustead Securities, LLCs client, Soliton, Inc., a pre-revenue stage medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center, today announced it has held the initial closing of its Regulation A+ Tier 2 offering. Soliton sold 2,086,39
2/15/19 - Cerecor Announces CERC-301 Granted U.S. Patent
Cerecor Inc., a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments in rare and orphan diseases in pediatrics and neurology, announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,202,363 on Feb. 12, 2019, which is directed to CERC 301, an oral, NR2B-specific, NMDA re
2/15/19 - Clinical Trial Supplies Market 2019: In-Depth Market Research Report Movianto (An Owens & Minor Company), Thermo Fischer Scientific, Catalent Pharma Solutions, Almac Group, Patheon, Clinigen Group
The Clinical Trial Supplies studies spreads fantastic statistics that makes the document a handy asset for managers, industry professionals and different key individuals alongside charts and tables to help recognize Clinical Trial Supplies market patterns, drivers and challenges. The development rate is based on the instructional exam of the facts
2/15/19 - Contract Research Organization (CRO) Market Business Growth and Opportunities 2019 to 2025
Harrisburg, NC 02/15/2019 Global Contract Research Organization Market Size, Status And Forecast 2025. This report studies the Global Contract Research Organization market size, industry status and forecast, competition landscape and growth opportunity. Food Service Market Segment by Region: North America, United States, Canada, Mexico, Asia-
2/15/19 - CymaBay Therapeutics Announces Seladelpar Granted Breakthrough Therapy Designation by the FDA for the Treatment of Primary Biliary Cholangitis
CymaBay Therapeutics, Inc., today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for seladelpar for the treatment of early stage primary biliary cholangitis in combination with ursodeoxycholic acid in adult patients with an inadequate response to UDCA, or as monotherapy in adults unable to tolera
2/15/19 - Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for Alzheimer's Disease
Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, today announced initiation of dosing in a Phase 1 b clinical study of DNL747 in patients with Alzheimer s disease, in collaboration with its partner Sanofi.. We are excited to advance DNL747 in a secon
2/15/19 - Electrolyte Analyzers Market Demand, Gross Margin, Industry Analysis, Business Opportunity and Forecast 2019 to 2025: Global Electrolyte Analyzers Industry report contains a complete product overview and its scope in the market to define the key term
Los Angeles, CA 02/15/2019 Electrolyte analyzers measure electrolyte levels in the human body to detect metabolic imbalances and measure renal and cardiac function. The electrolytes measured include sodium, potassium, chloride and bicarbonate. Electrolyte analyzers are used in hospital and reference laboratories, and also point of care settin
2/15/19 - Esoteric Testing Market Grow at a CAGR 11.2% During 2018-2025: Global Industry Top Key Players ACM Global Laboratories, Arup Laboratories, Fulgent Genetics, Invitae, Mayo Medical Laboratories
Top Key Competitors:* Quest Diagnostics* Opko Health* Miraca Holdings* Myriad Genetics* Sonic Healthcare* Primary Health Care* Healthscope* Foundation Medicine* ACM Global Laboratories* Arup Laboratories* Fulgent Genetics* Invitae* Mayo Medical Laboratories* Spectra Laboratories* Among Others. Global Esoteric Testing Market is expected to reach USD
2/15/19 - Establishment of TRICARE Select and Other TRICARE Reforms
Document Number: "Docket ID: DOD -2017- HA-0039". Agency: " Office of the Secretary, Department of Defense." The law makes significant changes to the TRICARE program, especially to the health maintenance organization- like health plan, known as TRICARE Prime; to the preferred provider organization health plan, previously known as TRICARE Extra and
2/15/19 - FDA Grants Priority Review to Merck's Supplemental Biologics License Application for KEYTRUDA (pembrolizumab) in Combination with Inlyta (axitinib) as First-Line Treatment for Advanced Renal Cell Carcinoma
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted and granted priority review for a new supplemental Biologics License Application for KEYTRUDA, Merck s anti-PD-1 therapy, in combination with Inlyta, a tyrosine kinase inhibitor, for the first-line treatment of patien
2/15/19 - Federal Register Extracts
Agency: " Centers for Medicare& Medicaid Services, HHS." FOR FURTHER INFORMATION CONTACT: Benjamin R. Cohen, Hearing Officer, Centers for Medicare& Medicaid Services, 2520 Lord Baltimore Drive, Suite L, Baltimore, MD 21244.. SUPPLEMENTARY INFORMATION: This notice announces the opportunity for an administrative hearing concerning the finding of the
2/15/19 - General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
SUMMARY: The Food and Drug Administration announces a forthcoming public advisory committee meeting of the General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee. ADDRESSES: FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room, Silver Spring, MD 20993-0002. Answers to commonly asked
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415